Skip to content

Clinical trials

Lysosomal Storage Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20082
20101
20114
20121
20142
20151
20171
20192
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical4
Alexion Pharmaceuticals, Inc.3
Shire3
Gemma Biotherapeutics1
Pfizer1
Sangamo Therapeutics1
Spark Therapeutics, Inc.1
Spur Therapeutics1
Sumitomo Pharma Switzerland GmbH1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases19
Mucopolysaccharidosis IV4
Cholesterol Ester Storage Disease3
Genetic Diseases, Inborn3
Lipid Metabolism Disorders3
Metabolic Diseases3
Metabolism, Inborn Errors3
Mucopolysaccharidosis II3
Sudden Infant Death3
Wolman Disease3

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.